Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,518.40 INR | -0.01% | -2.00% | +40.07% |
Chart calendar Aurobindo Pharma
Upcoming events on Aurobindo Pharma
Past events on Aurobindo Pharma
03/09/2024 08:00 am | Investor Meeting - Elara Capital |
29/08/2024 03:30 pm | Annual General Meeting |
21/08/2024 | Investor Meeting - IIFL Capital |
20/08/2024 08:00 am | Investor Meeting - Motilal Oswal |
20/08/2024 | Investor Meeting - IIFL Capital |
12/08/2024 08:30 am | Q1 2025 Earnings Call |
10/08/2024 06:33 pm | Q1 2025 Earnings Release |
18/06/2024 09:00 am | Investor Meeting - Nuvama |
13/06/2024 09:30 pm | Investor Meeting - ICICI Securities |
13/06/2024 02:30 pm | Investor Meeting - IIFL |
11/06/2024 06:30 pm | Investor Meeting - ICICI Securities |
11/06/2024 02:30 pm | Investor Meeting - Goldman Sachs |
10/06/2024 06:30 pm | Investor Meeting - ICICI Securities |
06/06/2024 12:00 pm | Investor Meeting - Bank of America |
30/05/2024 09:00 am | B&K Securities Trinity Investor Conference |
27/05/2024 08:30 am | Q4 2024 Earnings Call |
25/05/2024 06:51 pm | Q4 2024 Earnings Release |
13/03/2024 03:45 pm | Investor Meeting - Ad Factors |
06/03/2024 03:00 pm | Investor Meeting - ICICI Securities |
06/03/2024 10:30 am | Investor Meeting |
Past dividends on Aurobindo Pharma
20/02/2024 | Interim Payment 1.5 INR |
20/11/2023 | Interim Payment 3 INR |
17/02/2023 | Interim Payment 3 INR |
06/06/2022 | Interim Payment 4.5 INR |
18/02/2022 | Interim Payment 1.5 INR |
17/11/2021 | Interim Payment 1.5 INR |
27/08/2021 | Interim Payment 1.5 INR |
22/02/2021 | Interim Payment 1.5 INR |
23/11/2020 | Interim Payment 1.25 INR |
21/08/2020 | Interim Payment 1.25 INR |
17/02/2020 | Interim Payment 1.75 INR |
21/11/2019 | Interim Payment 1.25 INR |
15/02/2019 | Interim Payment 1.25 INR |
20/11/2018 | Interim Payment 1.25 INR |
20/02/2018 | Interim Payment 1 INR |
21/11/2017 | Interim Payment 1.5 INR |
08/06/2017 | Interim Payment 1.25 INR |
24/11/2016 | Interim Payment 1.25 INR |
09/06/2016 | Final Payment 0.7 INR |
18/02/2016 | Interim Payment 0.7 INR |
Annual results
Fiscal Period | March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 234 555 237 036 -1.05% | 248 554 247 239 0.53% | 290 019 286 709 1.15% | 316 437 | 348 106 | 364 101 |
EBITDA Million INR | Released Forecast Spread | 43 868 45 330 -3.23% | 37 070 38 043 -2.56% | 58 258 56 713 2.72% | 68 909 | 78 044 | 78 850 |
EBIT Million INR | Released Forecast Spread | 33 324 33 608 -0.84% | 24 624 25 879 -4.85% | 43 042 40 928 5.16% | 52 308 | 59 894 | 59 108 |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 33 727 36 490 -7.57% | 26 125 26 921 -2.96% | 43 800 43 538 0.6% | 54 311 | 62 765 | 65 049 |
Net income Million INR | Released Forecast Spread | 26 482 26 992 -1.89% | 19 275 20 241 -4.77% | 31 730 31 344 1.23% | 39 252 | 46 567 | 47 620 |
EPS INR | Released Forecast Spread | 45,2 46,1 -1.89% | 32,9 34,5 -4.67% | 54,2 53,3 1.56% | 67,2 | 79,7 | 82,2 |
Announcement Date | 30/05/22 | 27/05/23 | 25/05/24 | - |
Quarterly results
Fiscal Period | Marzo | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 62 359 59 939 4.04% | 57 394 63 014 -8.92% | 64 071 61 588 4.03% | 64 730 63 365 2.15% | 68 505 66 308 3.31% | 72 194 68 555 5.31% | 73 518 74 327 -1.09% | 75 802 73 148 3.63% | 75 972 | 78 046 | 78 207 | 79 190 | 84 584 |
EBITDA Million INR | Released Forecast Spread | 9 365 10 454 -10.42% | 7 896 10 357 -23.77% | 9 538 9 816 -2.83% | 9 963 9 877 0.87% | 11 514 10 789 6.72% | 13 734 11 963 14.81% | 16 013 15 419 3.85% | 16 602 15 236 8.96% | 16 182 | 18 131 | 17 706 | 17 591 | |
EBIT Million INR | Released Forecast Spread | 6 570 8 413 -21.91% | 4 915 7 990 -38.49% | 6 324 6 670 -5.19% | 6 508 6 704 -2.92% | 8 248 7 601 8.52% | 9 559 8 567 11.59% | 11 780 12 165 -3.16% | 13 058 11 190 16.69% | 13 114 | 13 703 | 13 474 | 13 540 | 15 859 |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 6 790 8 692 -21.88% | 5 234 8 433 -37.94% | 6 801 6 955 -2.21% | 7 301 6 814 7.15% | 8 120 7 748 4.81% | 10 756 8 800 22.23% | 12 624 11 846 6.57% | 12 299 11 498 6.96% | 13 363 | 14 000 | 13 984 | 13 869 | |
Net income Million INR | Released Forecast Spread | 5 205 6 315 -17.57% | 4 095 5 844 -29.94% | 4 913 5 671 -13.37% | 5 063 5 189 -2.44% | 5 708 5 777 -1.19% | 7 572 6 061 24.93% | 9 363 8 749 7.02% | 9 088 8 361 8.69% | 9 491 | 10 000 | 10 100 | 9 700 | |
EPS INR | Released Forecast Spread | 8,88 11,4 -21.8% | 6,99 10,6 -33.84% | 8,38 8,61 -2.67% | 8,64 8,96 -3.57% | 9,74 10,3 -4.98% | 12,8 10,7 20.36% | 16,0 16,3 -1.72% | 15,5 14,9 4.19% | 16,4 | 16,7 | 17,2 | 18,0 | 19,9 |
Announcement Date | 11/08/22 | 12/11/22 | 09/02/23 | 27/05/23 | 12/08/23 | 09/11/23 | 10/02/24 | 25/05/24 | - | - | - | - | - |
Past sector events for Aurobindo Pharma
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AUROPHARMA Stock
- Calendar Aurobindo Pharma
MarketScreener is also available in this country: United States.
Switch edition